NVTS insider sale filed: 250K shares via Goldman Sachs on 09/18/2025
Rhea-AI Filing Summary
Navitas Semiconductor Corp (NVTS) reports a proposed sale under Rule 144 of 250,000 common shares through Goldman Sachs & Co. LLC, scheduled approximately for 09/18/2025 with an aggregate market value listed as $1,682,500. The filing shows these shares were acquired from the issuer in a public offering on 10/19/2021 and that payment was made in full on that date. The company reports 213,107,277 shares outstanding. The notice also lists related sales in the past three months: 500,000 shares by Lola's Trust and 461,332 shares by GanFast Trust, both dated 09/10/2025, with gross proceeds of $2,827,200 and $2,610,308.72, respectively.
Positive
- None.
Negative
- None.
Insights
TL;DR: A small Rule 144 sale of 250,000 NVTS shares is scheduled; recent trust sales show additional insider-related liquidity.
This Rule 144 notice documents a proposed brokered sale of 250,000 common shares via Goldman Sachs with an indicated aggregate market value of $1,682,500. The shares were acquired in a public offering on 10/19/2021 and fully paid. The filing also discloses two trust sales on 09/10/2025 totaling 961,332 shares, generating combined gross proceeds of $5,437,508.72. Relative to the issuer's reported 213,107,277 outstanding shares, the proposed sale represents roughly 0.12% of outstanding shares, suggesting limited direct dilution or supply shock. The filing contains no statements of material adverse information and follows typical Rule 144 disclosure format.
TL;DR: Filing is a routine Rule 144 disclosure showing insider-related disposals and compliance representation.
The notice includes the standard certification that the seller is unaware of undisclosed material adverse information and references potential trading-plan representation. Acquisition details show purchase from the issuer in a public offering and no non-cash payment obligations. The presence of recent trust sales is relevant for monitoring insider liquidity patterns but the filing does not allege any regulatory issues or withheld disclosures. Documentation appears to meet Rule 144 reporting requirements based on the provided fields.